Actavis, Inc. News Headlines

ACT 
$302.09
*  
2.67
0.88%
Get ACT Alerts
*Delayed - data as of Mar. 31, 2015 13:47 ET  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ACT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







The Best Stocks To Buy This Week
3/30/2015 10:19:00 AM - Seeking Alpha




ETFs Capitalize on the Generic Industry’s Growth
3/28/2015 4:05:00 AM - Market Realist


What Drives Generic Pharmaceuticals’ Valuation?
3/28/2015 3:05:00 AM - Market Realist


What Helps a Generic Company Boost Its Profitability?
3/28/2015 3:05:00 AM - Market Realist




Complex Generics Are Attractive Due to High Margins
3/28/2015 2:05:00 AM - Market Realist




Affordable Pricing Is Driving the Generic Drug Market
3/28/2015 2:05:00 AM - Market Realist


Farallon Capital Increases Position in Covidien
3/28/2015 1:05:00 AM - Market Realist


Farallon Capital Increases Position in Allergan
3/28/2015 1:05:00 AM - Market Realist


Has Orexigen Delivered A Death Knell To Vivus?
3/27/2015 10:37:00 AM - Seeking Alpha






Top Large Cap Stocks That Investors Can Buy Now
3/26/2015 3:20:00 AM - Seeking Alpha




Is a Para IV Filing Rewarding for a Generic Company?
3/25/2015 3:06:00 PM - Market Realist




Why Is the Generics Industry Controlled by Regulations?
3/25/2015 1:05:00 PM - Market Realist